Using cDNA of the human poliovirus receptor (PVR) as a probe, two types of cDNA clones of the monkey homologs were isolated from a cDNA library prepared from an African green monkey kidney cell line. Either type of cDNA clone rendered mouse L celis permissive for poliovirus infection. Homologies of the amino acid sequences deduced from these cDNA sequences with that of human PVR were 90.2 and 86.4%, respectively. These two monkey PVRs were found to be encoded in two different loci of the genome. Evolutionary analysis suggested that duplication of the PVR gene in the monkey genome had occurred after the species differentiation between humans and monkeys. The NH2-terminal immunoglobulin-like domain, domain 1, of the second monkey PVR, which lacks a putative N-glycosylation site, mediated poliovirus infection. In addition, a human PVR mutant without N-glycosylation sites in domain 1 also promoted viral infection. These results suggest that domain 1 of the monkey receptor also harbors the binding site for poliovirus and that sugar moieties possibly attached to this domain of human PVR are dispensable for the virus-receptor interaction.
Poliovirus, a human enterovirus of the family Picomaviridae, is known to be the causative agent of poliomyelitis. The initial event of poliovirus infection is the attachment of the virus to its specific receptor on the cell surface. Subsequently, penetration and uncoating of the virus occur. Therefore, the cellular receptor for poliovirus (PVR), as well as those for other viruses, must play important roles in these early steps of infection as one of host cell factors that support viral replication. This conclusion, in turn, led to the notion that PVR is an important primary determinant of the host range specificity and tissue tropism of poliovirus infection (3, 9) .
Recently, both complementary and genomic DNA clones for human PVRs were isolated (11, 15) . Analyses of these DNAs revealed the following. (i) The human PVR gene, a member of immunoglobulin (Ig) supergene family, appears to occur once per haploid genome and is located at band q13.1-q13.2 of human chromosome 19. (ii) At least four PVR mRNA isoforms (PVRa, PVRI, PVR-y, and PVRb) are produced by alternative splicing both in cultured cells and in tissues of human origin. (iii) PVRa and PVRb are functional membrane-bound forms of PVRs and have possible structures corresponding to a signal peptide, three Ig-like domains, a transmembrane domain, and a cytoplasmic domain, where alternative splicing results in different amino acid sequences within the cytoplasmic domains of these two PVRs; PVRI and PVR-y, which lack regions including the transmembrane domain, are secreted forms of PVRs. Furthermore, human PVRs are strongly suggested to be glycoproteins, since (i) they have eight putative N-linked glycosylation sites and (ii) the apparent molecular weights of * Corresponding author.
PVRs are much higher than those of PVRs calculated from the deduced amino acid sequences (5, 25) .
It has been shown that the 160S poliovirus particle can be converted to a 135S particle during incubation with susceptible cells, their membranes, or the solubilized membrane fraction of cells which produce PVR (4, 6, 10) . This alternation of virion structure is believed to be the first step of the viral uncoating process. Of the three Ig-like domains of human PVRs, the NH2-terminal Ig-like domain, domain 1 , was proved to be essential for virus binding and possibly for uncoating (12, 20) . However, the fine structures of domain 1, which is required for the interaction with poliovirus, are not clear at present. For example, it has not been determined whether carbohydrate chains attached to PVRs play important roles in the early steps of poliovirus infection.
Although humans are the only natural host, poliovirus can be transferred to monkeys, in which it causes a similar paralytic disease. The disease syndrome observed in monkeys appears to result from lytic viral replication in limited tissues, such as neurons in the central nervous system as in humans (2, 8) . Other animal species are generally not sensitive to poliovirus. The characteristic species specificity of poliovirus may be due to cellular receptors accessible to poliovirus. Indeed, mouse L cells became susceptible to poliovirus when they were transformed with the genomic DNA clone of human PVR or cDNA clones of membranebound forms of PVR (11, 15) . Furthermore, transgenic mice carrying the human PVR gene acquired susceptibility to poliovirus (13, 17 (11) . An EcoRI-BamHI fragment of human PVRao cDNA (nucleotide positions 276 to 1227) was labeled with 32P and then used as a probe in plaque hybridization experiments. Plaque hybridization was carried out as previously described (11) except that the membranes were washed at 65°C in a buffer containing lx SSC (0.15 M NaCl plus 0.015 M sodium citrate) and 0.1% sodium dodecyl sulfate (SDS). DNA inserts that hybridized to the human PVR probe were subcloned into plasmid vector pUC118 or pUC119.
PVR DNA fragments were amplified by polymerase chain reaction (PCR) from DNA of AGMK cells or DNA of cynomolgus monkey liver, using the following synthetic primers: 5'-GATC£ITCiACGGGCGACTCCGTGACGCT GCCCTG-3', which had nucleotides 124 to 146 with the SalI site indicated by the underline, and 5'-GATCiGGATCC CAGGCAGGTGTAGTTGCCTTCATC-3', which had an antisense sequence from positions 348 to 372 with the BamHI site indicated by the underline (nucleotide numbering is that used in a report by Koike et al. [11] ). Reaction conditions were the same as described previously (11) . The PCR products were digested with SalI and BamHI and then inserted into plasmid vector pUC119 that had been treated with the same enzyme mixture. The nucleotide sequences were determined by the dideoxy-chain termination method (19 Fig. 1E]) . The nucleotide sequence of the mutant DNA was confirmed by sequencing. An EcoRI-EcoRV fragment of pSV2PVRd4 (12) was then replaced by the corresponding fragment of the mutant DNA. The plasmid thus obtained was designated pSV2PVRd4AG.
Expression of PVR cDNAs in mouse cells. Expression of PVR cDNAs isolated from JVK-03 cells was carried out essentially as described previously (11) . Briefly, cDNA fragments encoding either monkey PVR, AGMal or AGMa2, were inserted into the pSV2 expression vector by replacing the human PVR cDNA (the SacI site in the 5' noncoding region to the BgiII site in the 3' noncoding region; nucleotide positions -98 to 1686) of pSV2PVRa by corresponding fragments of either one of the monkey PVR cDNAs. These plasmids were designated pSV2AGMal and J. VIROL. x pSV2AGMa2, respectively. Plasmid pSV2AGMa2/d4 was constructed as follows. The SacI-EcoRV DNA fragment (nucleotide positions -98 to 406) of pSV2PVRd4 (12) was replaced by the SacI-EcoRV fragment (nucleotide positions -104 to 394) of pSV2AGMa2 ( Fig. 1) . Mouse Ltk-cells were transfected by the calcium phosphate method (1) with monkey PVR cDNA clones together with plasmid pTK, which encodes the herpes simplex virus thymidine kinase gene. Mouse cell transformants (Ltk+) were selected in DMEM supplemented with 10% fetal calf serum and 0.1 mM hypoxanthine-0.4 ,uM aminopterin-0.06 mM thymidine. Cell lines that produce monkey PVRs were established by limiting dilution.
Poliovirus infection. Mouse cell transformants were examined for their susceptibility to poliovirus by infection with the light-sensitive Mahoney strain of poliovirus type 1 essentially as described previously (11) . A total of 10 PFU of poliovirus was incubated in the dark with 106 cells (seeded in a 6-cm plastic dish) at room temperature for 30 min and then at 37°C for 30 min. The medium was changed under light exposure, and cells were further incubated at 37°C for 24 h. After three cycles of freezing and thawing, the cell lysates were centrifuged at 3,000 rpm for 10 min to remove cell debris, and virus titers in the supernatants were measured in JVK-03 cells.
Southern blot hybridization. Genomic DNA (10 (Fig. 2) . The amino acid sequences from positions 1 to 385 of AGMal and AGM&1 were identical to each other, but the remaining amino acid sequences were totally different. The amino acid sequence from 386 to 417 of AGMal was similar to that of the corresponding region of human PVRa (11) or H20A (15) (Fig. 2A) . Six of seven amino acids at the C terminus of AGMb1 were identical to those of the corresponding amino acids of human PVRb (11) or H20B (15) (Fig. 2B) . These results suggest that the mRNAs for AGMal and AGM81 are produced by alternative splicing from the primary transcript of a single gene, as suggested by the results of experiments involving the human PVR gene (11) . We performed PCR to detect cDNA clones which correspond to the human soluble PVR isoforms PVRO and PVRy, using a set of primers as described previously (11) . However, such isoforms were not detected among the 50 cDNA clones that hybridized to the human PVR cDNA.
The homologies of nucleotide and deduced amino acid sequences between monkey clones AGMal and AGMa2 are 94.1 and 92.5%, respectively ( Fig. 1 and 2 ). With respect to sequence homologies of the monkey clones with human PVRa, AGMal and AGMa2 had 93.7 and 90.8% nucleotide sequence identities and 90.2 and 86.4% amino acid sequence identities, respectively. The primary structure of the extracellular domain is highly conserved between human PVR and the monkey homologs, whereas the transmembrane and cytoplasmic domains are relatively variable. Details of the amino acid sequence homologies of the corresponding Iglike domains between human PVR and the monkey homologs AGMal and AGMa2 are shown in Fig. 1 . The primary structures of domains 2 and 3 are more conserved than that of domain 1 between human PVR and the monkey homologs (Fig. 1) .
Seven, six, and five putative N-glycosylation sites (Asn-X-Thr/Ser) were found in AGMal, AGMal', and AGMa2, respectively ( Fig. 1 and 2 ), suggesting that monkey PVRs are also glycoproteins. Five of six putative glycosylation sites observed in domains 2 and 3 of human PVRa are conserved in all of the monkey homologs, but those in domain 1 are not.
Functional analysis of AGMad and AGMca2. To determine the functions of AGMal and AGMa2 as receptors for poliovirus, cDNAs of both types of molecules were inserted into the expression vector pSV2 as described in Materials and Methods. They were designated pSV2AGMa1 and pSV2AGMa2, respectively, and the cDNAs were expressed in mouse L cells as previously described (11) . The transformants were examined for susceptibility to poliovirus infection. Virus titers measured at 24 h after infection are shown in Table 1 
T ACTATCCCCCAGAGGTATCCATCTCTGGCTATGATAACAACTGGT8ACCTCAGCCAGAATGAGGCCACCCTGACCTGCGACGCTCGCAGCAACCCAGAGCCCACAGGCTACAACTGGAGC 840 (12, 20) . Since the primary structures of human and monkey PVRs are highly conserved, it is likely that domain 1 of monkey PVRs also harbors the virus binding site. To test this possibility, a chimeric receptor cDNA between cDNAs of the deletion mutant of human PVR, PVRd4 (12), and AGMa2 was constructed as described in Materials and Methods. The chimeric receptor consisted of the complete domain 1 of AGMa2, the 20 NH2-terminal amino acids of domain 2 of human PVRa, and the transmembrane and cytoplasmic domains of human PVRa (Fig. 1D) . Mouse cells transformed with this chimeric cDNA were examined for susceptibility to poliovirus. As shown in Table 1 , the cells were susceptible to poliovirus infection, although the amount of progeny virus produced at 24 h after infection was smaller than those produced by other mouse cell transformants, and the spread of cytopathic effect was slower (data not shown). However, 48 h after infection, the virus yield reached the same level as for other transformants, and cytopathic effects were observed in all of the cells (data not shown). These results indicate that domain 1 of monkey PVR also contains the essential site for poliovirus infection, which suggests that the structural differences between monkey and human PVRs have little effect on their PVR function and that the mechanisms for the interaction of monkey PVRs with poliovirus are very similar or identical to those of human PVRs.
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Carbohydrate chains in domain 1 are not essential for receptor function. Among the amino acid differences between human and monkey PVRs, those which affect the formation of putative N-glycosylation sites are of particular interest. Since AGMa2/d4 is a functional PVR, it is clear that N-linked carbohydrate chains are not essential for its PVR function. This finding, in turn, suggests that N-linked carbohydrate chains, possibly attached to domain 1 of human PVRs, are not involved in the virus-receptor interaction. Although it is not known whether the two putative sites in domain 1 of human PVRs are actually glycosylated, a mutant human PVR lacking such N-glycosylation sites may be functional. Accordingly, we constructed a cDNA of a mutant human PVR in which two amino acids of the potential N-glycosylation motifs were substituted by the corresponding amino acids of AGMa2. These amino acid substitutions may provide a minimum change of the conformation in domain 1, because human and monkey PVRs appear to interact with poliovirus very similarly or identically, as described above. This mutant receptor, named PVRd4AG, which had no N-glycosylation site in the extracellular domain (Fig. 1E) To confirm this notion, genomic DNA of JVK-03 cells was analyzed by Southern blot hybridization after digestion with either BamHI, HindIII, or Nco. These enzymes do not digest the DNA region encoding domain 1 of AGMal and AGMa2. AnAatII-EcoRV fragment of human PVRa cDNA which covered most of the region of exon 2 of the human PVR gene was used as a probe. Since PCR cloning of this region from the genomic DNA was successful, as described above, domain 1 of monkey PVR, like that of human PVR (11) , must be encoded in a single exon. Therefore, a single band is expected in every Southern blot pattern if the PVR gene is located in one locus and a single type of allele. Two or more bands were detected in all DNA digests of JVK-03 DNAs (Fig. 3A) . Similarly, two bands were observed in digests of COS-7 cell DNA (Fig. 3B) . In contrast, Southern blot hybridization of DNA from HeLa cells showed a single band in all DNA digests with the different enzymes used (Fig. 3D) .
We further investigated DNAs from other African green monkeys to determine whether the monkeys generally have DNA sequences for both AGMal-type and AGMa2-type genes. COS-7 cells and four different preparation of primarycultured AGMK cells derived from the kidneys of individual African green monkeys were used for the study. Considering the history of these cells, it is unlikely that they were derived from relatives. We obtained PVR genomic DNA clones corresponding to the domain 1 shown in Fig. 4 It has been proved that domain 1 of human PVR is essential for virus infection (12, 20 (unpublished results) . It was proposed that the difference between the apparent molecular weight of PVR as estimated by gel electrophoresis and that calculated from the deduced amino acid sequence is due to glycosylation, a hypothesis supported by in vitro translation of human PVR-specific mRNA in the presence of dog pancreas microsome (25) . Although all of the putative N-glycosylation sites might not be glycosylated, the results presented here indicated that N-linked carbohydrate chains, if attached to domain 1, were dispensable. However, the efficiency of poliovirus infection of mouse cell transformants producing AGMa2/d4 or PVRd4AG was lower than that of transformants producing PVRd4 (12) . It is possible, therefore, that sugar moieties function to maintain an efficient interaction between virus and PVRs.
Lonberg-Holm (14) has shown that infection of poliovirus type 2 to HeLa cells is inhibited in the presence of concanavalin A (ConA). However, the inhibition of infection by ConA cannot be attributed to the direct binding of ConA to the poliovirus binding site in domain 1 of human PVRs, because the putative sugar moiety is dispensable for PVR function. The inhibition may be due to steric hindrance by ConA bound to PVR and/or other glycoproteins in the vicinity of PVR on the cell surface. Alternatively, ConA may restrict the lateral diffusion of membrane -glycoproteins caused by ConA binding. These data suggest that the protein moiety of domain 1 of PVR is important for the virusreceptor interaction. Extensive mutational analysis of domain 1 may reveal the amino acids critical for the interaction between poliovirus and PVRs.
In human cells, alternative splicing produces mRNA isoforms encoding secreted and membrane-bound forms of PVRs (11) . However, we failed to obtain cDNA clones encoding soluble forms of monkey PVRs that would correspond to the human mRNA isoforms for PVR,B and PVR-y. Furthermore, PCR amplification of the entire population of cDNAs of JVK-03 cells failed to yield DNA fragments that corresponded to mRNA isoforms for PVR, and PVR-y (data not shown). This observation suggests that alternative splicing producing soluble forms of monkey PVRs may occur only in specific cells or may not occur in any monkey cells. Alternatively, splicing for soluble forms of monkey PVR may occur by different mechanisms; i.e., another exon which does not contain the 3'-primer sequence is involved in the generation of soluble monkey PVRs.
The presence of two PVR loci in monkeys was demonstrated. There are two possible explanations for the different numbers of PVR loci between humans and monkeys. One is that a duplication of the PVR gene occurred after species differentiation between the human and monkey lineages. The other possibility is that the gene duplication had occurred before the species differentiation and then the second PVR locus was lost only in the human lineage. We have no direct evidence to rule out the latter possibility. The former possibility is, however, more likely because the sequence divergence between AGMal and AGMoa2 genes (2.6% synonymous changes) is much smaller than that between the human PVRat gene and AGMal or AGMa2 (5.1% synonymous changes). Since the cynomolgus monkey appears to have two PVR gene loci, it is possible that the gene duplication occurred before the divergence between cynomolgus and African green monkeys. A similar gene duplication event has been found in one species of the genus Mus; Mus spretus has two loci of the major urinary proteins, whereas other Mus species have only one. This gene duplication is believed to have occurred after the divergence of M. spretus from other Mus species (18) . The data provided in this study strongly indicate that poliovirus utilizes two types of PVRs when it infects monkeys. Distribution of functional PVRs in a host may constitute specific tissue and cell tropisms of poliovirus. An understanding of the virulence of poliovirus in monkeys may therefore depend on the elucidation of mechanisms that regulate the expression of both types of PVR genes. It should be stressed, however, that the progression of disease caused by poliovirus in monkeys seems to be identical to that in humans. Therefore, it is possible that the second PVR gene is expressed and utilized by poliovirus in the same manner as is the original PVR gene. This possibility suggests that the duplicated region of the monkey PVR gene includes the regulatory sequence of the original gene.
